Magazine
Latest Issue

Going mental

It’s time to establish rules for the use of cognitive-enhancing drugs by healthy people

Who could object to drugs that help people affected by mental disorders such as schizophrenia? Such treatments, known as pharmacological cognitive enhancers (PCEs) can improve memory, attention and motivation. Methylphenidate (Ritalin), for example, helps children with attention deficit hyperactivity disorder (ADHD) focus better in school, often making an important difference to their lives. Modafinil (Provigil) helps people stay awake and is licensed for the treatment of narcolepsy, a condition that causes sufferers to fall asleep involuntarily.

So far, so good. But the past few years have seen an unprecedented rise in the use of PCEs by healthy people. For…

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to letters@prospect-magazine.co.uk

More From Prospect